Genmab is an international biotechnology company dedicated to improving the lives of patients through innovative antibody therapeutics. The Evidence Generation Intern will support drug development efforts by gaining hands-on experience in Evidence Generation programs and assisting with various operational aspects of Investigator-Driven Programs.
Responsibilities
- Participate in successful implementation of Investigator-Driven and Managed Access Programs
- Support different governance meetings to drive and deliver on Evidence Generation Programs
- Support operational timelines and key deliverables
- Facilitate management of study or program proposal lifecycle from submission to study closure
- Support successful management of all aspects of investigator-driven programs within designated program budgets and timelines
- Collaborate with cross-functional teams and partners to manage, adjust, and revise project milestones as necessary
- Collaborate with EvGen team to generate regular metrics and reports of program activities
- Participate in mentorship meetings and contribute to team discussions on process improvements and best practices
Skills
- Enrolled in a Bachelor's or Advanced degree in a scientific discipline
- Strong analytical and problem-solving abilities
- Excellent written and verbal communication skills
- Ability to work independently and as part of a collaborative team
- Maintains attention to detail and quality in all deliverables while managing multiple tasks
- Basic understanding of clinical research is preferred
- Demonstrates initiative, a proactive attitude, and eagerness to learn in a fast-paced environment
- Effectively communicates and collaborates with team members, mentors, and stakeholders
Company Overview
Genmab is a biotechnology company focused on developing fully human antibody therapeutics for the potential treatment of cancer. It was founded in 1999, and is headquartered in Copenhagen, Hovedstaden, DNK, with a workforce of 1001-5000 employees. Its website is https://www.genmab.com.
Apply Now